Revital Aricha

Dr. Revital Aricha joined Chemomab in May 2022 with more than two decades of translational research experience in a wide variety of scientific fields. Previously Dr. Aricha served as Vice President of Research and Development at Brainstorm-Cell Therapeutics. In this role, she was instrumental in drug development, providing scientific support for advanced clinical trials and developing biomarker strategies. Earlier, Dr. Aricha was a senior scientist at the Department of Immunology of the Weizmann Institute of Science, where she specialized in novel treatments for autoimmune diseases. She received a BA and MA degree (magna cum laude) from Bar-Ilan University, where she also received her PhD in Neuroimmunology (summa cum laude). Dr. Aricha completed a postdoctoral fellowship at the Weizmann Institute of Science and has co-authored more than 30 scientific papers.